Status
Conditions
Treatments
About
In this study, the investigators will prospectively recruit 100,000 individuals, including gastric cancer patients who have not undergone any anti-tumor treatment and non-gastric cancer participants. The investigators will construct a diagnostic model for malignant tumors based on the combination of tongue imaging, tongue coating, saliva, gastric juice, and fecal multi-omics data (including metagenomics, proteomics, metabolomics, etc.). Additionally, the study will explore the relationship between oral, gastric, and intestinal microbiota and the development of malignant tumors.
Full description
Patients with gastric cancer were recruited through outpatient clinics, endoscopy units, and inpatient departments of various centers, with all patients requiring a histopathological diagnosis. Non-gastric cancer participants were sourced from community health check-ups, outpatient clinics, and endoscopy units affiliated with these centers.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria for Gastric Cancer Patients:
Exclusion Criteria for Gastric Cancer Patients:
Inclusion Criteria for Healthy Participants:
Exclusion Criteria for Healthy Participants:
100,000 participants in 2 patient groups
Loading...
Central trial contact
Xiangdong Cheng, MD; Zhiyuan Xu, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal